• 14th ISNI Congress

    14th International Congress of Neuroimmunology
    2nd Global Schools of Neuroimmunology Pre-Course

    August 27-31, 2018 - Brisbane, Australia

    Read more ...  
  • ASNI Charlottesville 2017

    2nd Americas School of Neuroimmunology

    October 3-6, 2017 - Charlottesville (VA), USA

    Read more ...  

    ISNI Session at the Immunology 2017 meeting

    Date: Monday, May 15, 2017
    Time: 10:15 AM - 12:15 PM

  • Registration and Abstract Submission

    Registration and Abstract Submission to the XXVI AINI Congress and 16th ESNI Course is open. Check it out here

  • Regeneration

    November 16-18, 2017, Milan Italy

    Read more ...  

Linington, Christopher




Phone: 00 44 141 330 8143
mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Chris Linington was awarded undergraduate and post graduate degrees in Biochemistry from the University of York, but subsequently developed an abiding interest in the immunobiology of multiple sclerosis while working with Professor Hartmut Wekerle in Germany.

His research focuses on understanding how immune and nervous system interactions are involved in driving the development of multiple sclerosis and other neurological diseases. He identified myelin oligodendrocyte glycoprotein as a dominant target for demyelinating autoantibodies in the central nervous system, and together with Hans Lassmann developed the concept that the development of demyelinating lesions may require both T cell and antibody-dependent effector mechanisms.

He was awarded the Sobek Research Prize for this work in 2003 and more recently identified Neurofascin as a target for autoantibody mediated axonal injury in multiple sclerosis. He is currently based at the University of Glasgow where he holds a chair in Neuroimmunology.

Joomla Template by